Vaxart Non Current Assets Total vs Retained Earnings Analysis
VXRT Stock | USD 0.82 0.01 1.23% |
Vaxart financial indicator trend analysis is much more than just breaking down Vaxart Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxart Inc is a good investment. Please check the relationship between Vaxart Non Current Assets Total and its Retained Earnings accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Non Current Assets Total vs Retained Earnings
Non Current Assets Total vs Retained Earnings Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaxart Inc Non Current Assets Total account and Retained Earnings. At this time, the significance of the direction appears to have pay attention.
The correlation between Vaxart's Non Current Assets Total and Retained Earnings is -0.73. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Vaxart Inc, assuming nothing else is changed. The correlation between historical values of Vaxart's Non Current Assets Total and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Vaxart Inc are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Non Current Assets Total i.e., Vaxart's Non Current Assets Total and Retained Earnings go up and down completely randomly.
Correlation Coefficient | -0.73 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Most indicators from Vaxart's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxart Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. Enterprise Value is likely to gain to about 130.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 21.2 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 70.6M | 110.4M | 86.2M | 44.6M | Cost Of Revenue | 48.7M | 3.3M | 4.5M | 4.3M |
Vaxart fundamental ratios Correlations
Click cells to compare fundamentals
Vaxart Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Vaxart fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 37.0M | 152.6M | 221.2M | 153.8M | 91.8M | 150.6M | |
Short Long Term Debt Total | 2.3M | 7.2M | 13.0M | 21.7M | 26.5M | 28.4M | |
Other Current Liab | 2.9M | 3.4M | 836K | 8.2M | 5.6M | 9.6M | |
Total Current Liabilities | 9.2M | 11.8M | 10.8M | 17.9M | 13.7M | 17.6M | |
Total Stockholder Equity | 13.0M | 123.4M | 187.5M | 110.6M | 57.8M | 89.3M | |
Property Plant And Equipment Net | 2.2M | 8.3M | 19.8M | 41.3M | 36.6M | 27.5M | |
Net Debt | (11.2M) | (119.7M) | (130.7M) | (22.3M) | (8.2M) | (8.7M) | |
Retained Earnings | (116.7M) | (148.9M) | (219.4M) | (327.1M) | (409.6M) | (389.1M) | |
Cash | 13.5M | 126.9M | 143.7M | 44.0M | 34.8M | 52.2M | |
Non Current Assets Total | 19.4M | 24.1M | 52.0M | 54.4M | 46.3M | 40.4M | |
Non Currrent Assets Other | 141K | 372K | 890K | 3.6M | 926K | 879.7K | |
Cash And Short Term Investments | 13.5M | 126.9M | 166.5M | 93.7M | 39.7M | 61.2M | |
Net Receivables | 3.6M | 334K | 71K | 20K | 3.0M | 2.9M | |
Common Stock Shares Outstanding | 21.6M | 88.3M | 121.5M | 127.7M | 144.8M | 152.1M | |
Liabilities And Stockholders Equity | 37.0M | 152.6M | 221.2M | 153.8M | 91.8M | 150.6M | |
Non Current Liabilities Total | 14.9M | 17.4M | 22.9M | 25.3M | 20.3M | 27.5M | |
Other Current Assets | 453K | 1.3M | 2.6M | 3.7M | 2.8M | 4.6M | |
Other Stockholder Equity | 129.6M | 272.3M | 406.9M | 438.0M | 467.4M | 490.7M | |
Total Liab | 24.1M | 29.2M | 33.6M | 43.3M | 34.0M | 44.6M | |
Property Plant And Equipment Gross | 2.2M | 8.3M | 19.8M | 15.6M | 43.4M | 24.7M | |
Total Current Assets | 17.6M | 128.5M | 169.2M | 99.5M | 45.5M | 43.3M | |
Accumulated Other Comprehensive Income | (1.6M) | (459K) | (74K) | (299K) | (1K) | (1.1K) | |
Short Term Debt | 841K | 2.1M | 1.0M | 2.2M | 6.5M | 6.8M | |
Intangible Assets | 17.1M | 15.4M | 10.6M | 5.0M | 4.3M | 4.1M | |
Accounts Payable | 852K | 2.1M | 3.9M | 5.5M | 1.6M | 1.5M | |
Common Stock Total Equity | 714K | 4.8M | 11K | 13K | 11.7K | 11.1K | |
Common Stock | 714K | 5K | 11K | 13K | 15K | 14.3K | |
Current Deferred Revenue | 4.6M | 4.2M | 5.1M | 2M | 1.8M | 1.7M | |
Other Liab | 13.4M | 14.9M | 10.9M | 5.9M | 6.7M | 7.9M | |
Net Tangible Assets | 13.0M | 123.4M | 187.5M | 110.6M | 127.2M | 67.4M | |
Other Assets | 141K | 372K | 890K | 3.6M | 4.1M | 4.3M | |
Retained Earnings Total Equity | (116.7M) | (148.9M) | (219.4M) | (327.1M) | (294.4M) | (279.7M) | |
Capital Surpluse | 124.8M | 272.3M | 406.9M | 438.0M | 503.7M | 528.9M | |
Property Plant Equipment | 210K | 1.5M | 6.6M | 15.6M | 17.9M | 18.8M |
Pair Trading with Vaxart
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxart position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxart will appreciate offsetting losses from the drop in the long position's value.Moving together with Vaxart Stock
0.8 | EQ | Equillium | PairCorr |
The ability to find closely correlated positions to Vaxart could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxart when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxart - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxart Inc to buy it.
The correlation of Vaxart is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxart moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxart Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxart can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Vaxart Stock analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Vaxart's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxart. If investors know Vaxart will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxart listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Revenue Per Share 0.058 | Quarterly Revenue Growth 2.231 | Return On Assets (0.47) | Return On Equity (1.12) |
The market value of Vaxart Inc is measured differently than its book value, which is the value of Vaxart that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxart's value that differs from its market value or its book value, called intrinsic value, which is Vaxart's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxart's market value can be influenced by many factors that don't directly affect Vaxart's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxart's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxart is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxart's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.